Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adamas Pharmaceuticals
Adamas Pharmaceuticals
(ADMS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Microcrystalline cellulose
healthy volunteers/patients
,
non-small-cell lung carcinoma
,
gram-positive bacterial infections
,
liver failure
,
hepatic insufficiency
,
renal insufficiency
,
renal dialysis
,
skin diseases
,
dengue
,
pancreatic neoplasms
,
stomach neoplasms
,
heart failure
,
wound infection
,
ovarian neoplasms
,
melanoma
,
gastroparesis
,
lung neoplasms
,
small cell lung carcinoma
,
lymphoma
,
cytomegalovirus infections
,
hodgkin disease
,
gestational diabetes
,
pneumococcal pneumonia
,
carcinoma
,
breast neoplasms
,
non-hodgkin lymphoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
b-cell chronic lymphocytic leukemia
,
pneumococcal infections
,
infections
,
communicable diseases
,
bacterial skin diseases
,
insulin resistance
,
chronic renal insufficiency
,
bacterial infections
,
rheumatoid arthritis
,
arthritis
,
hiv-1
,
acquired immunodeficiency syndrome
,
antibiotic prophylaxis
,
crohn disease
,
chronic kidney failure
,
herpes zoster
,
hyperlipidemias
,
islets of langerhans transplantation
,
type 2 diabetes mellitus
,
diabetes mellitus
,
neoplasms
,
prediabetic state
,
hypoglycemia
,
glucose intolerance
,
vomiting
,
nausea
,
atherosclerosis
,
fibrosis
,
cystic fibrosis
,
hospitalization
,
hyperglycemia
,
obesity
,
diabetic foot
,
foot ulcer
,
adipose tissue neoplasms
,
cardiovascular diseases
,
type 1 diabetes mellitus
Potassium magnesium citrate (4:1:2)
healthy volunteers/patients
,
gram-positive bacterial infections
,
non-small-cell lung carcinoma
,
pancreatic neoplasms
,
stomach neoplasms
,
ovarian neoplasms
,
melanoma
,
liver failure
,
hepatic insufficiency
,
heart failure
,
gastroparesis
,
renal insufficiency
,
renal dialysis
,
skin diseases
,
wound infection
,
dengue
,
lung neoplasms
,
small cell lung carcinoma
,
lymphoma
,
cytomegalovirus infections
,
hodgkin disease
,
carcinoma
,
breast neoplasms
,
non-hodgkin lymphoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
gestational diabetes
,
b-cell chronic lymphocytic leukemia
,
pneumococcal pneumonia
,
pneumococcal infections
,
infections
,
communicable diseases
,
bacterial skin diseases
,
insulin resistance
,
chronic renal insufficiency
,
bacterial infections
,
hiv-1
,
acquired immunodeficiency syndrome
,
antibiotic prophylaxis
,
crohn disease
,
islets of langerhans transplantation
,
hyperlipidemias
,
chronic kidney failure
,
herpes zoster
,
type 2 diabetes mellitus
,
diabetes mellitus
,
neoplasms
,
prediabetic state
,
hypoglycemia
,
glucose intolerance
,
vomiting
,
nausea
,
hospitalization
,
hyperglycemia
,
atherosclerosis
,
adipose tissue neoplasms
,
diabetic foot
,
foot ulcer
,
fibrosis
,
cystic fibrosis
,
obesity
,
type 1 diabetes mellitus
,
cardiovascular diseases
Fluzone
human influenza
Potassium nitrate
healthy volunteers/patients
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
b-cell lymphoma
,
b-cell chronic lymphocytic leukemia
,
leukemia
,
lymphoid leukemia
,
lymphoma
,
type 2 diabetes mellitus
,
anemia
,
follicular lymphoma
,
human influenza
Flumist
human influenza
Flucelvax
human influenza
Isoxaflutole
postoperative nausea and vomiting
,
vomiting
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use